Hannah Abrams, MD

@HannahRAbrams

Sarcoma Doctor. Social media @JCOOP_ASCO host @CuriousClinPod. Hope to improve patient/caregiver experiences in cancer care. Views my own.

Seattle, WA Joined April 2011

1.3K Following 6.6K Followers 2.9K Posts

Latest posts 5

Hannah Abrams, MD @HannahRAbrams 2d

Congratulations @wagsmd @immunosarc on the immense effort to get this research on JAK1 inhibition for #leiomyosarcoma out there!

Suzie Siegel @SuzieSiegel 4d

A phase 1 trial of itacitinib, a JAK1 inhibitor, suggests it may be beneficial in immunotherapy combinations for leiomyosarcoma. #sarcoma tandfonline.com/doi/full/10.10…
View quoted post on X

Hannah Abrams, MD @HannahRAbrams 3d

In oncology, some might call this a curve a truck could drive through:

John Mandrola, MD Verified account @drjohnm 3d

Might be the silliest claim of noninferiority ever
View quoted post on X

Hannah Abrams, MD @HannahRAbrams 4d

Duffy-Null specific reference ranges for ANC from @ASH_hematology.

I know more guidelines forthcoming, but @Jmarksloan is there any expert guidance on how/when to dose reduce chemotherapy, Rx ppx antibiotics during chemo in this setting?

J Mark Sloan @Jmarksloan 5d

We now have Duffy-null reference ranges for adults and children.

Next step-
understand and accomodate Duffy null status when considering eligibility for clinical trial inclusion, medications (eg azathioprine) or dose reductions (eg for chemo)

tinyurl.com/2r46zrb2
View quoted post on X

Hannah Abrams, MD @HannahRAbrams Oct 29

How should we reimburse health systems for 'metronomic' -- high frequency, small quantity -- cancer care? G2211 is a start toward this but doesn't really capture the work that goes into being so constantly available and reviewing someone's data.

Rahul Banerjee, MD, FACP Verified account @RahulBanerjeeMD Oct 29

Pleasure learning from @LouisWilliamsMD, an expert in both myeloma and AI!

Part 1 of our two-part "AI in blood cancers" podcast: How routine clinical care will shift, e.g. 👇🏼

Part 2 (stay tuned): Research-focused... with AIs like this, can we finally get rid of CROs??? 🤞🏻

View quoted post on X

Hannah Abrams, MD @HannahRAbrams Oct 27

Interesting idea from @ravi_b_parikh: can the data that patients put in to the EMR, like PROs, help “fact check” AI ambient scribe notes?

Key questions, though: does this just offset more work onto the patient? How to account for if (when) people don’t fill out the survey?